Skip to main content

Table 1 Clinical and imaging characteristics

From: Evaluating effects of normobaric oxygen therapy in acute stroke with MRI-based predictive models

  Control-treated (n = 6) NBO-treated (n = 10)
  Mean ± SD (Median) Mean ± SD (Median)
Age (y) 71 ± 18 (71) 67 ± 16 (70)
Female 4 (67%) 5 (50%)
Time Intervals   
Symptom onset to admission MRI (h) 4.4 ± 2.0 (4.4) 7.3 ± 4.5 (5.9)
Admission-to-treatment MRI (h) 5.0 ± 1.4 (4.8) 4.3 ± 1.5 (3.9)
Admission-to-post-treatment MRI (h) 24.8 ± 1.9 (24.8) 24.4 ± 1.5 (24.2)
Admission-to-discharge MRI (d) 6.7 ± 1.9 (6.6) 6.0 ± 1.4 (5.8)
Acute NIHSSS 11 (9-12) 14 (9-18)
Reperfusion   
Admission-to-treatment 1 (17%) 0
Treatment to post-treatment 0 5 (50%)
Measured Lesion Volume (cm 3 )   
Admission DWI 27 ± 44 (8) cm3 37 ± 24 (30) cm3
4 h DWI 28 ± 34 (15) cm3 35 ± 25 (27) cm3
24 h DWI 32 ± 39 (15) cm3 49 ± 37 (43) cm3
Discharge 41 ± 48 (23) cm3 66 ± 42 (53) cm3
Lesion Change (%)   
4h* 153 ± 96 (134)% 90 ± 22 (90)%
24h 186 ± 142 (148)% 129 ± 29 (134)%
Discharge 223 ± 91 (203)% 192 ± 81 (178)%
  1. *P = 0.036 Control-group vs NBO-group